Menu
ncarol.com
  • Home
  • Books
  • Education
  • Technology
  • Book Release
  • Health
  • Entertainment
  • Real Estate
  • Music
ncarol.com

Isosceles Pharmaceuticals, Inc. Appoints William D. Humphries as its Chief Executive Officer
ncarol.com/10114932

Trending...
  • Altruvest and Financial Executives International Canada Announce Strategic Partnership to Strengthen Nonprofit Boards Across Canada
  • 5,521 College Athletes Launch Own Merch Stores in Just 30 Days on AthleteMerch.com, Reaching 7,975 Live Storefronts Nationwide
  • Postmortem Pathology Opens Sacramento Office Offering Private Autopsies for Families and Healthcare Investigations
WILMINGTON, N.C., May 5, 2021 /PRNewswire/ -- Isosceles Pharmaceuticals Inc. a biotechnology company dedicated to developing, commercializing, and marketing innovative non-opioid products for the treatment of mild to moderate pain and inflammatory diseases, today announced the appointment of William D. Humphries as its Chief Executive Officer. Mr. Humphries is a highly accomplished executive leader in the pharmaceutical industry with a proven track record leading several global pharmaceutical companies.

"We are excited to welcome Bill for the role of Chief Executive Officer," said Tim Wright, Chairman of Isosceles Board of Directors. "His extensive background in the pharmaceutical industry will provide invaluable leadership as Isosceles achieves its strategic growth milestones."

Most recently, Mr. Humphries served as President of Ortho Dermatologics, a subsidiary of  Bausch Health Companies. He has also held global executive leadership positions at Merz North America, GlaxoSmithKline, Stiefel, and Allergan.

"I would like to thank Tim and the Isosceles team for welcoming me to company," said Mr. Humphries, Chief Executive Officer of Isosceles. "I was attracted to Isosceles by their focus on the pursuit of innovative solutions for safe, novel non-opioid pain relief and the passion the team has for delivering these important products to the market. I look forward to leveraging my experience to accelerate the company's development plans and lead Isosceles as it unlocks its full potential."

More on ncarol.com
  • Matthew Cossolotto Spotlights Make a Promise Day 2026 Events, Including Official Launch of Harness Your PromisePower and Issuing a "Peace Promise"
  • Landmark Expands Services to Include Specialized Glass and Glazing Solutions Across Los Angeles
  • As Pentagon Releases Ufo Files, Debut Ya Novel Predicted It All
  • RAATV Premieres Original Reality Series "The Access Index: Jackson" June, 19
  • Connecticut Resident Develops Patent-Pending Concept Exploring a New Approach to GPS Navigation

Mr. Humphries currently serves as Chairman of the Board at Clearside Biomedical, Chairman of the North Carolina State University Global Luxury Management Board, is a member of the Board at Aclaris Therapeutics, and a member of the Board at Strata Skin Sciences. He received his MBA from Pepperdine University and completed his undergraduate studies at Bucknell University.

About Isosceles Pharmaceuticals, Inc.

Isosceles Pharmaceuticals is a preclinical stage biotechnology and medical device company focused on the delivery of drug master file backed synthetic cannabinoids for their anti-inflammatory and pain relief properties. The Company's proprietary formulations coupled with unique delivery platforms provide high bioavailability via parenteral and transdermal routes.

Investor Contact
Brett Lanier
[email protected]

SOURCE Isosceles Pharmaceuticals, Inc.

Related Links

www.isoscelespharma.com
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • ICTPBX Released: White-Label, Multi-Tenant Open Source PBX Platform for ITSPs
  • 5,521 College Athletes Launch Own Merch Stores in Just 30 Days on AthleteMerch.com, Reaching 7,975 Live Storefronts Nationwide
  • Altruvest and Financial Executives International Canada Announce Strategic Partnership to Strengthen Nonprofit Boards Across Canada
  • Free Critical Illness Claim Calculator Launches to the Public
  • PBSA Announces Kellie O'Shea as 2026–27 Secretary/Treasurer
  • HRC Fertility Celebrates Beverly Hills Grand Opening, Spotlighting Fertility Care as Women's Health Month Begins
  • New from Regal House Publishing, A Confluence of Strangers, a found body - a mystery friends pursue
  • HRC Fertility's Dr. Christo G. Zouves Appointed to San Mateo County Medical Association Board of Directors
  • HealthBook+ and Stonebrook Risk Solutions Partner to Bring Predictive Intelligence to Healthcare Risk
  • Umbrella Becomes First FinOps Platform to Support AWS Billing Transfer Onboarding
  • RECYCLEXPERT FZE Strengthens Leadership in Data Destruction UAE and GCC with Certified Secure ITAD Services
  • Assymetrix Launches the Deepest Independent Prediction Market Data API
  • CCHR: 'Plant-Based' Psychedelics Push Masks Synthetic Drugs and Billion-Dollar Profits
  • BTR: i2 Group Launches i2 Amplify, a Community Platform for Intelligence Professionals Worldwide
  • L.A. Watts Summer Games Announces Free Pelé Tribute Event at Magic Johnson Park
  • TMO Global Comms Expands Ecosystem with Launch of TMORRISONPR IMPRINT®
  • SUMOFIBER Fuels Explosive Growth With netElastic vBNG
  • NRx Pharmaceuticals (N A S D A Q: NRXP) Accelerates Into National Spotlight as Manufacturing Launch, Federal Policy & AI-Driven Breakthroughs Converge
  • Stonewood Cottage Coworking by David Alexander Properties is a Best of North Carolina® Winner
  • Expanding Into High-Margin Battery Recycling With Black Mass Strategy plus Scaling AI Infrastructure & Global Supply Chain Platform: N A S D A Q: MWYN
_catLbl0 _catLbl1

Popular on ncarol.com

  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis - 124
  • Sycor Introduces Spring Release 2026 of Sycor.Rental with AI-Driven Innovations and Enhanced Service Processes - 112
  • Advanced TeleSensors Appoints AgeTech Innovator Tiffany Wey, MBA as Vice President of Sales & Marketing - 106
  • Pacific Emblem Company Launches "Happy 250th Birthday America" Collection and Proud Supporter of the Gary Sinise Foundation - 102
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA) - 101
  • Bold Beauty Project Celebrates Anniversary with Collaborative Exhibition at FIU's Miami Beach Urban Studios
  • Most Americans Choose Their Water Brand Because of Its Natural Source — Yet Fewer Than 3 in 10 Understand What Spring Water Actually Is
  • $112 Million Contract Backlog for Cycurion (N A S D A Q: CYCU) Enters Hyper-Growth Phase With, Strategic Acquisitions, & Exploding AI Cybersecurity
  • CCHR Report Links 145 Violent Incidents to Psychiatric Drug Exposure, Urges National Oversight and Action
  • Appliance EMT Presents Multi-Thousand Dollar Donation to Kids Motel Ministry to Support Local Families

Similar on ncarol.com

  • RAS AP Consulting Advances to Request for Proposal Stage in Heidelberg Materials' SAP Customer & Vendor Master Data Modernization Initiative
  • David Cavanagh Launches AI SEO Company For ChatGPT And AI Search Visibility
  • Matthew Cossolotto Spotlights Make a Promise Day 2026 Events, Including Official Launch of Harness Your PromisePower and Issuing a "Peace Promise"
  • Resident Inspect Joins Property Meld Nexus Network with API Integration
  • Veikkaus Appoints New CFO as Finland's Gambling Monopoly Braces for Breakup
  • NRx Pharmaceuticals (N A S D A Q: NRXP) Accelerates Into National Spotlight as Manufacturing Launch, Federal Policy & AI-Driven Breakthroughs Converge
  • Expanding Into High-Margin Battery Recycling With Black Mass Strategy plus Scaling AI Infrastructure & Global Supply Chain Platform: N A S D A Q: MWYN
  • More Life Summit 2026 Announces Gary Brecka & Mr. Olympia Derek Lunsford as First Speakers for Miami Event
  • Bellwether Farm Presents Kerry Hill Lamb to His Majesty King Charles III During Historic U.S. State Visit
  • Postmortem Pathology Opens Sacramento Office Offering Private Autopsies for Families and Healthcare Investigations
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute